Golimumab

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1735 publications

Golimumab in Treatment-Refractory Hidradenitis Suppurativa.

Golimumab in Treatment-Refractory Hidradenitis Suppurativa.

Journal: JAMA dermatology

Published: June 10, 2026

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Journal: Journal of Crohn's & colitis

Published: May 20, 2026

Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition.

Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition.

Journal: The Journal of dermatological treatment

Published: May 06, 2026

TNF-alpha Inhibitor-Induced Pulmonary Sarcoidosis

TNF-alpha Inhibitor-Induced Pulmonary Sarcoidosis

Journal: Pneumologie (Stuttgart, Germany)

Published: May 04, 2026

Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study.

Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study.

Journal: Expert opinion on biological therapy

Published: April 23, 2026

Golimumab-Associated Myocarditis with Progressive Eosinophilia after Route Switch in Rheumatoid Arthritis.

Golimumab-Associated Myocarditis with Progressive Eosinophilia after Route Switch in Rheumatoid Arthritis.

Journal: European journal of case reports in internal medicine

Published: April 21, 2026

Therapy Persistence and Dose Escalation of Advanced Treatments in First and Second Line of Ulcerative Colitis and Crohn's Disease - A Retrospective Cohort Analysis of Healthcare Claims Data.

Therapy Persistence and Dose Escalation of Advanced Treatments in First and Second Line of Ulcerative Colitis and Crohn's Disease - A Retrospective Cohort Analysis of Healthcare Claims Data.

Journal: Zeitschrift fur Gastroenterologie

Published: April 21, 2026

Pulmonary rheumatoid nodules in a patient treated with golimumab.

Pulmonary rheumatoid nodules in a patient treated with golimumab.

Journal: ARP rheumatology

Published: April 12, 2026

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.

Journal: The Journal of rheumatology

Published: April 01, 2026

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

Journal: The Journal of rheumatology

Published: April 01, 2026

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

Journal: The Journal of rheumatology

Published: April 01, 2026

Considerations for infection risks identified in target safety review.

Considerations for infection risks identified in target safety review.

Journal: The Journal of toxicological sciences

Published: April 01, 2026

Showing 1-12 of 1,735

Last Updated: 06/30/2026